Home › Penile Cancer
Penile Cancer clinical trials recruiting in the U.S.
7 studies for Penile Cancer are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03866382E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT05639972E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT05686226A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT04923178Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · Men · Updated Jun 8, 2026 · NCT06104618Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
RecruitingPhase 2
Ages 18 and older · Men · Updated Dec 4, 2025 · NCT05526989From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.